See also this year's filing and all EDGAR filings for this company.
PDF Report 0001420720_2022_iBio_Inc.pdf
Logs
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 17, '00201 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss CALC2': 3}} |
Graph
Absolute values for 0001420720, iBio Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 104,597,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 952,000 |
| 2 | PropertyPlantAndEquipmentNet | 8,628,000 |
| 3 | remainder_Assets | 32,791,000 |
| 4 | LiabilitiesCurrent | 6,645,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 31,755,000 |
| 7 | CostOfGoodsAndServicesSold | 1,462,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 22,031,000 |
| 9 | ResearchAndDevelopmentExpense | 9,989,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 2,371,000 |
| 12 | remainder_NetIncome | 7,898,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 146,968,000 |
| 1 | Liabilities | 38,400,000 |
| 2 | Expenses | 33,482,000 |
| 3 | Revenues | 2,371,000 |
| 4 | StockholdersEquity | 108,568,000 |
| 5 | NetIncome | -23,213,000 |
| 6 | ComprehensiveNetIncome | -23,213,000 |
| 7 | BaseVar | 114,559,500 |
| 8 | EconomicCapitalRatio | 1.76 |
Edgar->Model Mapping
Feature Distribution
Change over Time
